In a significant development for the National Health Service (NHS), the government has achieved its interim target for hospital treatment waiting times in England, with 65.3% of patients treated within 18 weeks as of March 2026. This milestone, while an encouraging step forward, comes amidst a backdrop of internal political strife and persistent challenges within the health system. Wes Streeting, the outgoing Health Secretary, heralded the achievement as a sign of progress but resigned shortly after, citing a need for renewed leadership.
Milestone Achieved, But at What Cost?
The achievement of the 65% target is viewed as a preliminary milestone on the road towards an ambitious goal of treating 92% of patients within the same timeframe by the end of the current parliamentary term in 2029. When Labour took office, the figure was alarmingly low, at below 59%. Streeting lauded the current administration’s efforts, attributing the improvement to investment, modernisation, and the dedication of NHS staff across the country. “It means we are right on track to deliver the fastest reduction in waiting times in the history of the NHS,” he stated, emphasizing the need for continued efforts.
However, the overall improvement in national statistics does not reflect a uniform enhancement across the board. Alarmingly, nearly 40% of hospital trusts failed to meet their individual targets, with ten trusts reporting a deterioration in their performance. This inconsistency raises questions about the equitable distribution of resources and the effectiveness of strategies employed.
Mixed Results on Waiting Lists
In terms of the overall waiting list, there has been a slight decrease, with the numbers falling from 7.2 million to 7.1 million—the lowest recorded figure in three and a half years. Sir Jim Mackey, the Chief Executive of NHS England, described this moment as “huge,” underscoring that progress in patient care extends beyond mere statistics. He attributed this achievement to the resilience of NHS staff, who have continued to deliver care despite facing disruptions from frequent strike actions by junior doctors.
Yet, experts caution against complacency. Tim Mitchell from the Royal College of Surgeons of England highlighted that while staff are working tirelessly, their efforts are hampered by chronic under-investment in facilities and essential equipment. “Too many teams are still working in ageing buildings with too few theatres and beds,” he noted. Without addressing these systemic constraints, the sustainability of current progress remains uncertain.
Funding Concerns and Future Sustainability
The interim target’s success was partly facilitated by additional government funding since January, enabling hospitals to ramp up their efforts in anticipation of the March deadline. Sarah Woolnough, Chief Executive of the King’s Fund, expressed concern about the sustainability of this funding model. “It brings into question whether reaching the eventual 92% target by rinsing and repeating this sequence of ‘elective sprints’ is financially feasible or manageable for already stretched NHS staff,” she remarked. Furthermore, she pointed out that the exclusive focus on the 18-week target masks the reality that several other waiting lists are continuing to grow, suggesting a need for a broader strategy.
Why it Matters
The achievement of the interim target is a notable development for the NHS, reflecting both dedication and resourcefulness amid ongoing challenges. However, the mixed results among hospital trusts and the precarious nature of funding raise critical questions about the future of patient care. As the government faces pressures to maintain and build upon this progress, it must also consider the broader implications of its policies on healthcare delivery. The journey towards meeting the 92% target will not only require sustained investment but also a reassessment of priorities within the health system to ensure that all patients receive timely and equitable care.
